In this report, the biomarkers market is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers. The applications segments included in this report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications. The disease indications segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases.

The geographic segments included in this report are North America, Europe, Asia, and the Rest of the World (RoW).

The growth of this market is mainly driven by increasing healthcare expenditure, increase in R&D spending, increasing utility of biomarkers for diagnostics, increasing number of CROs, the low cost of clinical trials in developing countries, and new initiatives for biomarker research. The high growth potential in emerging markets and the increasing adoption of personalized medicine and companion diagnostics provides new growth opportunities to players in the biomarkers market.

A combination of bottom-up and top-down approaches were used to calculate the market sizes and growth rates of the global biomarkers market and its subsegments. Secondary information was used to identify overall revenue, geographic reach, and product portfolios of market players. Estimates of the biomarkers market segment revenues were validated through primary interviews. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates.

The report provides qualitative insights on key market shares, growth rates, and market drivers for important subsegments. It maps the market sizes and growth rates of each segment and identifies segments poised to witness rapid growth. The report includes company profiles and a competitive landscape of the biomarkers market. The company profiles include the financial performances, product portfolios, and developments of each company, whereas, the competitive landscape covers the growth strategies adopted by industry players over the last three years. The report also includes analyses of industry developments such as acquisitions, agreements, collaborations & partnerships; new product launches; and other developments.

Reasons to Buy the Report:

The report will enable both established firms and new entrants to gauge the pulse of the market and make important strategic growth decisions.

The report provides insights on the following:
• Product Development/Innovation: Product portfolios of the top players in the biomarkers market. Detailed insights on upcoming technologies, R&D activities, and new product launches in the biomarkers market
• Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the biomarkers market
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various biomarkers across geographies
• Market Diversification: Exhaustive information about new products, recent developments, and investments in the biomarkers market

Figure 1 Biomarkers Market
Figure 2 Research Design
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 6 Data Triangulation Methodology
Figure 7 Biomarkers Market Size, By Product, 2015 vs 2020 ($Billion)
Figure 8 Market Size, By Type, 2015 vs 2020 ($Billion)
Figure 9 Market Size, By Application, 2015 vs 2020 ($Billion)
Figure 10 Market Size, By Disease Indication, 2015 vs 2020 ($Billion)
Figure 11 Market Size, By Region, 2015 vs 2020 ($Billion)
Figure 12 Global Biomarkers Market to Witness High Growth During the Forecast Period
Figure 13 Consumables Segment to Account for the Largest Market Share in 2015
Figure 14 Asia to Witness Highest Growth Rate in the Forecast Period
Figure 15 Asian Market Shows Lucrative Growth Opportunites
Figure 16 Biomarkers Market: By Product
Figure 17 Biomarkers Market: By Type
Figure 18 Biomarkers Market: By Application
Figure 19 Biomarkers Market: By Disease Indication
Figure 20 Biomarkers Market: Drivers, Restraints, Opportunities, and Challenges
Figure 21 Increasing Healthcare Expenditure is the Most Important Driver for the Market
Figure 22 Increasing R&D Investments Boosting Growth in the Market
Figure 23 Biomarkers Market, By Product
Figure 24 Consumables Segment to Command the Largest Share of the Biomarkers Market in 2015
Figure 25 North America Will Be the Largest Regional Segment of the Consumables Market in 2015
Figure 26 Asia to Be the Fastest-Growing Regional Segment of the Biomarker Services Market Between 2015 and 2020
Figure 27 North America to Command the Largest Share of the Biomarker Software Market in 2015
Figure 28 Biomarkers Market, By Type
Figure 29 Safety Biomarkers to Command the Largest Share of the Market in 2015
Figure 30 Asia to Be the Fastest-Growing Regional Segment for Safety Biomarkers in the Forecast Period
Figure 31 Efficacy Biomarkers Market, By Type
Figure 32 Predictive Biomarkers Segment to Command the Largest Share of the Efficacy Biomarkers Market in 2015
Figure 33 North America to Be the Largest Regional Segment for Efficacy Biomarkers in 2015
Figure 34 Asia to Be the Fastest-Growing Regional Segment of the Predictive Biomarkers Market Between 2015 and 2020
Figure 35 North America to Command the Largest Share of the Surrogate Biomarkers Market in 2015
Figure 36 Asia to Be the Fastest-Growing Regional Segment for Pharmacodynamic Biomarkers in the Forecast Period
Figure 37 North America to Be the Largest Regional Segment of the Prognostic Biomarkers Market in 2015
Figure 38 Asia to Be the Fastest-Growing Regional Segment for Validation Biomarkers Between 2015 and 2020
Figure 39 Biomarkers Market, By Application
Figure 40 Diagnostics Development to Command the Largest Share of the Market in 2015
Figure 41 North America is Expected to Be the Largest Regional Market for Diagnostics Development
Figure 42 Asia to Be the Fastest-Growing Regional Segment in the Drug Discovery and Development Market
Figure 43 North America to Command the Largest Share of the Personalized Medicine Market in 2015
Figure 44 Asia is the Fastest-Growing Regional Segment for Disease Risk Assessment
Figure 45 North America to Command the Largest Share of the Market for Other Applications
Figure 46 Biomarkers Market, By Disease Indication
Figure 47 Cancer Will Be the Largest Disease Indication Segment of the Biomarkers Market in 2015
Figure 48 North America to Be the Largest Regional Segment for Biomarkers for Cardiovascular Disorders in 2015
Figure 49 Asian Biomarkers Market for Neurological Disorders to Grow at the Highest Rate
Figure 50 North America to Command the Largest Share of the Biomarkers Market for Immunological Disorders in 2015
Figure 51 Asia to Be the Fastest-Growing Regional Segment of the Biomarkers Market for Other Disease Indications
Figure 52 Global Economic Indicators (2003–2012)
Figure 53 Market Size and Growth Rate, By Region, 2015-2020
Figure 54 Market in Asia to Witness Highest Growth Rate From 2015 to 2020
Figure 55 North America: Economic Indicators (2003–2012)
Figure 56 North America: Market Snapshot
Figure 57 Consumables is Estimated to Be the Largest Product Segment of the North American Biomarkers Market in 2015
Figure 58 Safety Biomarkers to Command the Largest Share of the North American Biomarkers Market By 2020
Figure 59 Predictive Biomarkers Segment Will Continue to Dominate the Efficacy Biomarkers Market in North America
Figure 60 Diagnostics Development Segment to Account for the Largest Share of the North American Biomarkers Applications Market in 2015
Figure 61 Cancer to Account for the Largest Disease Indication Segment of the North American Biomarkers Market in 2015
Figure 62 U.S.: Economic Indicators (2003–2012)
Figure 63 Consumables to Account for the Largest Share of the U.S. Biomarkers Products Market in 2015
Figure 64 Safety Biomarkers to Form the Largest Segment of the U.S. Biomarkers Market in 2015
Figure 65 Predictive Biomarkers Will Continue to Dominate the Efficacy Biomarkers Market in the U.S.
Figure 66 Diagnostics Development to Command the Largest Share of the U.S. Biomarkers Applications Market in 2015
Figure 67 Cancer to Form the Largest Disease Indication Segment of the U.S. Biomarkers Market in 2015
Figure 68 Canada: Economic Indicators (2003-2012)
Figure 69 Consumables to Account for the Largest Segment of the Canadian Biomarkers Products Market in 2015
Figure 70 Safety Biomarkers to Dominate the Canadian Biomarkers Market By 2020
Figure 71 Predictive Biomarkers Will Continue to Dominate the Canadian Efficacy Biomarkers Market
Figure 72 Diagnostics Development Segment to Account for the Largest Share of the Canadian Biomarkers Market in 2015
Figure 73 Cancer to Form the Largest Disease Indication Segment of the Canadian Biomarkers Market in 2015
Figure 74 Europe: Economic Indicators (2003–2012)
Figure 75 Consumables is Estimated to Be the Largest Product Segment of the European Biomarkers Market in 2015
Figure 76 Safety Biomarkers to Account for the Largest Share of the European Biomarkers Market in 2015
Figure 77 Predictive Biomarkers to Account for the Largest Share of the European Efficacy Biomarkers Market in 2015
Figure 78 Diagnostics Development Segment to Account for the Largest Share of the European Biomarkers Applications Segment in 2015
Figure 79 Cancer to Form the Largest Disease Indication Segment of the European Biomarkers Market in 2015
Figure 80 Asia: Economic Indicators (2003–2012)
Figure 81 Asia: Market Snapshot
Figure 82 Market Snapshot
Figure 83 Consumables is Estimated to Be the Largest Segment of the Asian Biomarkers Market in 2015
Figure 84 Safety Biomarkers to Account for the Largest Share of the Asian Biomarkers Market in 2015
Figure 85 Predictive Biomarkers to Account for the Largest Share of the Asian Efficacy Biomarkers Market in 2015
Figure 86 Diagnostics Development to Account for the Largest Share of the Asian Biomarkers Applications Market in 2015
Figure 87 Cancer to Form the Largest Disease Indication Segment of the Asian Biomarkers Market in 2015
Figure 88 Rest of the World: Economic Indicators (2003–2012)
Figure 89 Consumables Segment is Expected to Account for the Largest Share of the RoW Biomarkers Products Market in 2015
Figure 90 Safety Biomarkers to Account for the Largest Share of the RoW Biomarkers Market in 2015
Figure 91 Predictive Biomarkers to Account for the Largest Share of the RoW Efficacy Biomarkers Market in 2015
Figure 92 Diagnostics Development to Account for the Largest Share of the RoW Biomarkers Applications Market in 2015
Figure 93 Cancer to Form the Largest Disease Indication Segment of the RoW Biomarkers Market in 2015
Figure 94 New Product Launch, the Key Strategy Adopted By Players in the Market
Figure 95 Market Share Analysis, By Key Players, 2014
Figure 96 Financial Performance of Leading Market Players
Figure 97 Company Snapshot: Bio-Rad Laboratories, Inc.
Figure 98 Company Snapshot: EKF Diagnostics Holdings, Inc.
Figure 99 Company Snapshot: ENZO Biochem, Inc.
Figure 100 Company Snapshot: Merck & Co, Inc.
Figure 101 Company Snapshot: Perkinelmer, Inc.
Figure 102 Company Snapshot: Qiagen N.V.

マイクロフルイディクス（微少流体技術）の世界市場：材料（ポリマー、ガラス、シリコン）、用途、地域別分析Over the past five years, the microfluidics market has witnessed tremendous growth primarily due to rising demand for point-of-care (POC) testing, increasing use of miniaturized microfluidic chips to achieve faster testing and improved portability, and increased prevalence of age-related and lifestyle diseases and disorders. The global microfluidics market is expected to grow at a significant CAGR of around 19% during the forecast period (2015 to 2020). The market is mainly driven by the rising geriatric population, growing Asian healthcare market, and upsurge in government and corporate funding for R&D. However, lack of adequate healthcare and research infrastructure in emerging markets,...

レーザー・キャプチャ・マイクロダイセクション（LCM）の世界市場：製品（消耗品、装置、ソフトウェア）、システム、用途、需要先、地域別分析The global laser capture microdissection market is expected to USD 124.97 million by 2020 from USD 72.45 million in 2015, at a CAGR of 11.52% between 2015 and 2020. By product, the market includes instruments, consumables, and software and services. The consumables product segment is further classified into reagents and media, assay kits, and other consumables. Based on application, the market is segmented into research and development, diagnostics, and other applications. The research and development application segment is further classified into molecular biology, cell biology, and forensic science. The research and development segment will account for the largest share of...

アプリケーション・コントロールの世界市場：構成要素、アクセスポイント、企業規模、産業別、地域別分析MarketsandMarkets forecasts the application control market size to grow from USD 1.25 Billion in 2015 to USD 1.90 Billion by 2020, at a Compound Annual Growth Rate (CAGR) of 8.7% from 2015 to 2020. The major factors driving the growth of the market are the need to protect data against internal and external threats and the limitations of traditional security solutions to secure applications and data running on corporate endpoints. Furthermore, due to a rise in the demand for integrated security solutions, the market finds huge opportunity to proliferate in the next five years. The scope of this report covers...

癌バイオマーカーの世界市場：タンパク質バイオマーカー、ジェネティックバイオマーカーIn this report, the biomarkers market is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers. The applications segments included in this report are diagnostics development, drug discovery and development, personalized medicine, disease risk assessment, and other applications. The disease indications segments included in this report are cancer, cardiovascular disorders, neurological disorders, immunological disorders, and other diseases. The geographic segments included in this report are North America, Europe, Asia, and the...

組織検査の世界市場：免疫組織化学、in situハイブリダイゼーション、デジタルパソロジー、ワークフロー管理、特殊染色法The global tissue diagnostics market is valued at USD 3,202.5 Million in 2015 and expected to reach USD 4,471.1 Million by 2020, at a CAGR of 6.9% from 2015 to 2020. A major driver for the growth of the tissue diagnostics industry is the increasing prevalence of cancer. On the other hand, the high degree of consolidation, stringent regulatory requirements, and lack of budgets are restraining the growth of this market. However, the high growth potential in emerging economies and the increased use of personalized medicine will provide new growth opportunities to players in the market. This report segments the...

モバイルマネーの世界市場：トランザクションモード、支払方式、位置、購買種類、産業、地域別分析MarketsandMarkets forecasts the mobile money market size to grow from USD 21.15 Billion in 2016 to USD 112.29 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 39.64% from 2016 to 2021. Technological advancement in mobile devices, indispensable requirement to have ubiquitous access to financial solutions, rising use of non-cash payments, creation of new business avenues for stakeholders, evolving demographic needs across regions, rising use of mobile money services across businesses are some of the driving forces in the market. The scope of this report covers the mobile money market by location, type of purchase, vertical, transaction mode,...

ヒト・マイクロバイオームの世界市場：プロバイオティクス、食品、プレバイオティクス、医療食品、診断デバイス、医薬品、サプリメントThe human microbiome market is segmented by application, disease, product, and geography while the human microbiome research spending market is broadly segmented by product and technology. The human microbiome market is expected to reach USD 658 Million by 2023 from USD 294 Million in 2019 growing at a CAGR of 22.3% during the forecast period (2019–2023). The market is driven by growing incidences of unhealthy lifestyle diseases, and increase in occurrence of autoimmune disorders. However, government regulation and lack of detailed research may restrain the growth of this market to an extent. Investing in probiotic and prebiotic products, medical foods,...

仮想現実（VR）の世界市場：仮想現実技術、デバイス、構成要素、用途、地域別分析The virtual reality technology is a three-dimensional artificial environment, where the user can experience and interact with the virtual world. This technology is used in various applications such as gaming, entertainment, and for simulation and training purposes in aerospace, defense, medical, industrial, retail and marketing, and education applications. The market for virtual reality technology was valued at $980.4 million in 2014 and is projected to reach $15,899.1 million by 2020, at a CAGR of 63.18% between and 2020. The virtual reality technology market is growing considerably due to the technological advancements in virtual reality devices such as HMDs and the...

自動車エアコンの世界市場：技術、構成品（コンプレッサー、エバポレータ、ドライヤ/レシーバー、コンデンサ）、車両種類、地域別分析The automotive air conditioning market is projected to witness considerable growth in various vehicle types such as passenger cars, LCVs, HCVs, and Off-highway, due to technological advancement and increasing vehicle production. The Asia-Pacific region is estimated to dominate the automotive air conditioning market. The growth can be attributed to the increasing demand for vehicles, across the region. In 2015, the passenger car production in countries such as China and India is expected to grow at a faster rate, which will boost the automotive air conditioning market. The availability of cheap labor, and supportive government policies is attracting a majority of...

止血剤の世界市場：トロンビン、酸化再生セルロース、併用止血剤、ゼラチン、コラーゲンThe global hemostats market is projected to reach USD 2.76 Billion by 2020 at a CAGR of 6.2% from 2015 to 2020. The Americas market contributed the largest share to the global market in 2014, wherein the U.S. dominating the Americas market. The report on global hemostats market analyzes and segments the market on the basis of product and region. It analyzes the competitive developments, such as alliances, joint ventures, and mergers & acquisitions in the global market. This market is also analyzed with an explicit focus on the high-growth applications and fastest-growing market segments. Hemostats helps stop bleeding during...

マルチコプター・ドローンの世界市場：用途別、ペイロード別、地域別分析The multirotor drones market report offersa complete analysis of the market across the forecast period of five years from 2015 to 2020. It provides an analysis of the factors that drive the market, restrain the growth of the market, and the challenges faced by the industry. The major factors driving the market are the increasing use of drones in law enforcement and for non-military applications. However, the strict airspace regulations and defense budget cuts in some nations are restraining the growth of this market. The report discusses the key industry, market, and technology trends that influence the multirotor drones market....

熱可塑性プラスチック管の世界市場：プラスチック種類（PE、PVDF、PVC、PP、PA）、用途、地域別分析The report provides a detailed analysis of thermoplastic pipes used in varied applications such as oil & gas, municipal, mining & dredging, and chemical. The market has also been categorized on the basis of region into Asia-Pacific, North America, Europe, the Middle East & Africa, and Latin America. The market has been further segmented based on the type of polymer used for manufacturing these pipes. The report further provides a qualitative analysis of the leading players, with a clear insight and analysis on the development strategies preferred and adopted by them. The report also includes a chronology of developments with...

整形外科用装具および支持具の世界市場予測The increasing number of accidents and rising number of cases of osteoarthritis, osteoporosis, and other bone disorders has led to increased research activities for treatments that help heal bone injuries. In this report, the global orthopedic braces & supports market has been analysed and segmented based on type, end-user, and region. This market has also been analyzed with an explicit focus on the high-growth type and fastest-growing market segments. The report analyzes the competitive developments, such as new product launch, joint venture, and merger & acquisition in the global orthopedic braces market. Orthopedic braces and supports are designed to protect,...

防水システムの東南アジア市場：既成膜（変性瀝青、PVC、TPO、EPDM）、塗膜（エラストマー、セメント混合、歴青質）、統合システム（ポアブロッキング剤、結晶防水剤）、防水化学品 （瀝青、エラストマー、PVC、TPO、EPDM、コンクリート）The market size of Southeast Asia waterproofing systems market is estimated to reach USD 5.35 Billion by 2021, at a CAGR of 14.52% during the forecast period. The rising demand for waterproofing is backed by the growing building & construction industry in the region, especially in the developing countries, such as Indonesia, Malaysia, Thailand, Singapore, and Vietnam. Rapid growth in the construction industry made it the largest contributor to the market in Southeast Asia in 2015. The Southeast Asia waterproofing systems market is segmented into preformed membranes, liquid applied membranes, integral systems, and waterproofing chemicals. In 2015, the preformed membranes...

ウイルス不活化の世界市場：製品（キット、試薬、装置、サービス）、用途、方法、エンドユーザー、地域別分析The global viral inactivation market is valued at USD 320.5 Million in 2016 and is expected to grow at a CAGR of 12.3%, to reach USD 573.0 Million by 2021. Viral inactivation is important and mandatory step in the manufacturing process of biological products to remove or inactivate potential contaminant viruses. These biological products are used for the treatment and diagnostic purposes in humans. As the disease burden in the world is increasing the demand for the medicines is increasing hence the production of biologicals, injectables etc., is on a rise. Also, many of pharmaceutical and biotechnology firms are gearing...